Allergan PE Ratio 2006-2018 | AGN

Current and historical PE ratio for Allergan (AGN) from 2006 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Allergan (AGN) as of March 31, 2018 is 10.24.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $15.941B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $23.317B 6.10
Mylan (MYL) United Kingdom $18.315B 7.74
Dr Reddy's Laboratories (RDY) India $4.918B 29.37
Supernus Pharmaceuticals (SUPN) United States $2.842B 35.63
Akorn (AKRX) United States $2.188B 10.85
AxoGen (AXGN) United States $1.901B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.800B 3.03
Assembly Biosciences (ASMB) United States $0.860B 0.00
Homology Medicines (FIXX) United States $0.805B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.788B 73.48
Adamas Pharmaceuticals (ADMS) United States $0.731B 0.00
CymaBay Therapeutics (CBAY) United States $0.729B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.609B 0.00
Voyager Therapeutics (VYGR) United States $0.604B 0.00
Corium (CORI) United States $0.286B 0.00
Teligent (TLGT) United States $0.226B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.107B 0.00
Versartis (VSAR) United States $0.073B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.071B 0.00
Aevi Genomic Medicine (GNMX) United States $0.056B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.030B 0.00
Acasti Pharma (ACST) Canada $0.021B 0.00
Agile Therapeutics (AGRX) United States $0.017B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00